Taiho Oncology to Present Data at the 2025 ASCO Gastrointestinal Cancers Symposium
Findings to be shared from a study analyzing real-world clinical outcomes of patients with metastatic colorectal cancer (mCRC) who received trifluridine and tipiracil (FTD/TPI) monotherapy or FTD/TPI + bevacizumab (FTD/TPI+bev)


